Algert Global LLC’s Eli Lilly & Co Position
Does Algert Global LLC own Eli Lilly & Co (LLY)? Yes — 15.6K shares worth $14M (+0.22% of its 13F portfolio) as of Q1 2026, up from 14.9K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
15.6K
% of Portfolio
+0.22%
Quarters Held
15
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 15.6K | $14M | +0.22% |
| Q4 2025 | 14.9K | $16M | +0.25% |
| Q3 2025 | 15.1K | $12M | +0.19% |
| Q2 2025 | 13.6K | $11M | +0.22% |
| Q1 2025 | 13.1K | $11M | +0.27% |
| Q4 2024 | 12.3K | $9M | +0.22% |
| Q3 2024 | 10.9K | $10M | +0.26% |
| Q2 2024 | 504 | $456,000 | +0.02% |
| Q1 2024 | 394 | $307,000 | +0.01% |
| Q4 2023 | 1.0K | $603,000 | +0.02% |
| Q3 2023 | 974 | $523,000 | +0.02% |
| Q2 2023 | 5.4K | $3M | +0.11% |
| Q1 2023 | 5.2K | $2M | +0.08% |
| Q4 2022 | 4.5K | $2M | +0.09% |
| Q2 2022 | 5.9K | $2M | +0.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Algert Global LLC’s full portfolio or all institutional holders of LLY.